Medgenics completes follow-on

Medgenics Inc. (NYSE-M:MDGN), Vienna, Va. Business: Gene/Cell therapy, Drug delivery Date completed: 2014-12-01 Type: Follow-on Raised: $24.2 million Shares: 5.9 million Price: $4.10 Shares after offe...